Skip to main content
SpringerLink
Log in

Neuer Androgenrezeptorblocker in Kombination mit Androgendeprivation bei mCSPC

  • Uroonkologie
  • Literatur kompakt
  • Published:
Im Fokus Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

© modifiziert nach Chi KN et al. N Engl J Med. 2019;381(1):13-24

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Urologie und Kinderurologie, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany

    Katharina Böhm & Igor Tsaur

  2. Freie Medizinjournalistin, Witzlebenstr. 3, 14057, Berlin, Germany

    Kathrin von Kieseritzky

Authors
  1. Katharina Böhm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Igor Tsaur
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kathrin von Kieseritzky
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Katharina Böhm.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Böhm, K., Tsaur, I. & von Kieseritzky, K. Neuer Androgenrezeptorblocker in Kombination mit Androgendeprivation bei mCSPC. Im Fokus Onkologie 23, 63–64 (2020). https://doi.org/10.1007/s15015-019-0748-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15015-019-0748-4

Search

Navigation